Published in Rheumatol Int on August 10, 2016
Post-Transcriptional Regulation of Toll-Interacting Protein in the Intestinal Epithelium. PLoS One (2016) 0.78
Translating epigenetics into clinic: focus on lupus. Clin Epigenetics (2017) 0.75
Identification of aminosulfonylarylisoxazole as microRNA-31 regulators. PLoS One (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
The impact of microRNAs on protein output. Nature (2008) 32.39
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73
Systemic lupus erythematosus. N Engl J Med (2011) 7.79
Identification of a putative regulator of early T cell activation genes. Science (1988) 6.62
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 5.51
IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol (2007) 5.31
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med (2009) 3.78
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 3.44
Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum (2005) 3.03
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity (2013) 2.69
MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol (2010) 2.63
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol (2008) 2.57
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci Transl Med (2013) 2.03
Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol (1995) 1.89
Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem (2006) 1.84
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 1.81
Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol (1999) 1.56
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.54
Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis (2011) 1.49
Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Arthritis Rheum (2010) 1.45
Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med (2011) 1.38
Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev (2008) 1.31
Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum (1978) 1.29
Review: Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus (2009) 1.24
The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol (2010) 1.13
MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest (2015) 1.09
The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol (1987) 1.06
Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis (2006) 1.02
Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol (2010) 0.99
IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells. J Immunol (2014) 0.98
MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol (2016) 0.97
MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis. Immune Netw (2014) 0.88
miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun (2013) 0.87
IL-2 production by dendritic cells promotes Foxp3(+) regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity (2011) 0.87
Immunodeficiency in IL-2-knockout mice. Clin Immunol Immunopathol (1995) 0.86
Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus. Lupus (2014) 0.85
The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal (2013) 0.83
MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clin Dev Immunol (2013) 0.83
Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.81
Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J Leukoc Biol (2007) 0.81
MicroRNA-21 deficiency protects from lupus-like autoimmunity in the chronic graft-versus-host disease model of systemic lupus erythematosus. Clin Immunol (2015) 0.80
miRNAs in the Pathogenesis of Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.80
microRNA-126 expression and its mechanism of action in patients with systemic lupus erythematosus. Eur Rev Med Pharmacol Sci (2015) 0.79
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.79
MicroRNAs in the key events of systemic lupus erythematosus pathogenesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2016) 0.79
Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2011) 0.78
The clinical significance of decreased T cell interleukin-2 production in systemic lupus erythematosus: connecting historical dots. Arthritis Rheum (2010) 0.77
Epigenetics in systemic lupus erythematosus. Biomed Rep (2015) 0.75
Impact of Hepatitis C Virus/Schistosoma mansoni Coinfection on the Circulating Levels of HCV-NS4 Protein and Extracellular-Matrix Deposition in Patients with Different Hepatic Fibrosis Stages. Am J Trop Med Hyg (2016) 0.75
HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma. Tumour Biol (2015) 0.75